Navigation Links
Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
Date:2/27/2008

39,310 42,521 153,575 149,381

General and administrative 13,997 17,441 56,336 78,319

Impairment of long lived

assets(1) 28,396 8,254 28,396 9,410

Litigation Settlement 1,583 - 1,583 17,710

Amortization of other intangible

assets 236 708 946 4,039

Gain on termination of

collaborative agreements,

net (2) (79,178) - (79,178) -

Total operating costs and expenses 28,392 110,066 309,175 376,948

Income (Loss) from operations 37,381 (40,162) (36,148) (159,230)

Interest income 5,757 6,330 22,201 23,646

Interest expense (4,230) (5,458) (18,638) (20,793)

Other Income 944 1,263 1,133 2,444

Income (Loss) before provision for

income taxes 39,852 (38,027) (31,452) (153,933)

Provision for income taxes 809 828 1,309 828

Net income (loss) $39,043 $(38,855) $(32,761) $(154,761)

Basic and diluted net earnings

(loss) per share $0.42 $(0.43) $(0.36) $(1.72)

Shares used in computing basic and

diluted net earnings (loss) per

share (3) 92,211 90,499 91,876 89,789

Notes to Consolidated Statements of Operations

(1) In Q4, the company conducted an evaluation and determined that

uncertainties exist regarding the use of certain equipment and

facilities related to Exubera manufacturing. As a result, Nektar

recorded a non-cash impairment charge in Q4 of $28.4 million related

to the write-down of these assets.

(2) Gain on termination of c
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financial Markets
2. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
3. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
4. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
6. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
7. Prime Therapeutics Receives TIPPS Certification
8. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
9. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
10. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
11. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Meaningful long-term survival is possible for selected patients ... treated with cytoreductive surgery with Hyperthermic IntraPeritoneal Chemotherapy, ... physicians at Wake Forest Baptist Medical Center. , ... experience with cytoreductive surgery and HIPEC, said lead ... 20 years, worth of patient data shows that ...
(Date:4/17/2014)... per cent of Canadians surveyed said they would participate ... specific number of genetic conditions, only 80 per cent ... that would sequence their newborns, genomes.,Most newborns in North ... day or two of life in which a tiny ... tested for about five to 54 conditions, depending on ...
(Date:4/17/2014)... have called for more research to be carried ... in sub-Saharan Africa. In a paper in ... Stothard, working with colleagues in the department of ... in Cleveland Ohio, University of Cambridge and the ... the joint burden of HIV/AIDS and schistosomiasis of ...
(Date:4/16/2014)... ANTONIO, Texas (April 16, 2014) A team that includes ... Texas Health Science Center at San Antonio, Johns Hopkins University ... that helps a common fungus to infect the body. , ... diaper rashes and oral thrush, and is the most common ...
(Date:4/15/2014)... nearly half of all injuries aboard commercial freezer-trawlers and ... operating off the coast of Alaska, new research from ... and others aboard the two types of vessels could ... methods used in the study could help identify and ...
Breaking Medicine News(10 mins):Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3Health News:More research called for into HIV and schistosomiasis coinfection in African children 2Health News:Changes in processing, handling could reduce commercial fishing injuries 2
... skilled negotiators when it comes to relationships and the ... of Gothenburg, Sweden. The thesis examines what children ... use. The results show that young children are skilled ... children learn, through play, which negotiation strategies are appropriate ...
... Findings worrisome because thyroid hormones play critical role in ... News) -- Exposure to flame-retardant chemicals may reduce a ... a critical role in fetal brain development, a new ... are used in a large number of consumer products, ...
... and Dora to market treats should be banned, researcher ... cartoon characters are influencing the taste preferences of very ... new study suggests. , Researchers found that the branding ... Dora the Explorer drives preschoolers to choose higher-calorie, less ...
... ... you might hope to want or need for the sunny weather to come! , ... London, UK (PRWEB) June 19, 2010 -- The summer is pretty much ... best. Fear not, for anyone stuck in London without so much as a grain of sand in ...
... ... Horizon Healthcare Services, Inc. to Put Evidence-Based Medicine into Practice with Via Oncology Pathways ... Pittsburgh ... will continue to improve as a result of wider application of Via Oncology™ Pathways, ...
... ... form of release and expression, and now it has been fine-tuned to deliver mental rejuvenation ... ... this world, it can be difficult for the average person to relax or even get ...
Cached Medicine News:Health News:Young children are skilled negotiators 2Health News:Flame Retardant May Up Risk of Thyroid Problems in Pregnancy 2Health News:Cartoon Characters Sell Kids on Unhealthy Foods 2Health News:Cartoon Characters Sell Kids on Unhealthy Foods 3Health News:Summer is Here - The Best Value Luxury Manicures, Spa Packages and Spa Waxing from Kuno Tierra, Mayfair Spa 2Health News:Hematology-Oncology Associates of Northern New Jersey (HOANNJ) Joins Effort to Improve Cancer Care with Via Oncology™ Pathways 2Health News:Hematology-Oncology Associates of Northern New Jersey (HOANNJ) Joins Effort to Improve Cancer Care with Via Oncology™ Pathways 3Health News:Reinvent your Mental State With Brainwave Entrainment Relaxation Music 2Health News:Reinvent your Mental State With Brainwave Entrainment Relaxation Music 3Health News:Reinvent your Mental State With Brainwave Entrainment Relaxation Music 4
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2
... Watson Pharmaceuticals, Inc. (NYSE: WPI ), a ... intends to release its first quarter 2011 financial results on ... U.S. financial markets.  The Company will also host a conference ... 27, 2011 to discuss its financial results and provide an ...
... RESMED INC. (NYSE: RMD ), announced today that ... for the third quarter and nine months of fiscal year ... results will be issued after 1:00 p.m. Pacific Time and ... review its results, market trends, and future outlook. ...
Cached Medicine Technology:Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings 2ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2011 Results 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: